Life Sign Covid-19/Flu A & B Tests (25 tests per box)

A Rapid Immunoassay for the Simultaneous Direct Detection and Differential Diagnosis of SARS-CoV-2, Influenza Type A and Type B Antigen from anterior nasal and nasopharyngeal swab specimens.

Packaging: 25 tests per Box

Features:

• Anterior nasal swab specimen – Sensitivity 93.8%, Specificity 100%.
• Nasopharyngeal – Sensitivity 93.1%, Specificity 100%.
• Flu A – Sensitivity 91.4%, Specificity 95.7%.
• Flu B – Sensitivity 87.6%, Specificity 95.9%.
• FDA Emergency Use Authorization (EUA).
• Visually read in 15 minutes.
• Flocked nasopharyngeal swab for superior specimen collection and patient comfort.

[section bg=”#F2FFDB” title=”” padding=”20px” parallax_text=”0″ parallax=”0″ margin=”10px”]

REIMBURSEMENT

For code 33225, Status Covid-19 Flu A&B, please submit using all of the below CPT codes.
Average National Reimbursement per CPT codes are:
$41.38 for COVID-19: CPT code 87811
$16.41 for Flu A; CPT code 87804QW
$16.41 for Flu B; CPT code 87804QW-5
$74.20 Total for the 33225 combo COVID/Flu A&B

Total for 25 tests = Up to $1,855.00
[/section]

MADE IN USA
Status™ COVID-19/Flu A&B test kits are manufactured in the USA.

This product is authorized for use at the Point of Care (POC), i.e.,
in patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation.

To attain a CLIA Certificate of Waiver 

This product has been authorized only for the detection of proteins
from SARS-CoV-2, influenza A and influenza B, not for any other viruses or pathogens.

To attain a CLIA Certificate of Waiver / Application